Critical Review on the Anti-Tumor Activity of Bioactive Compounds from Edible and Medicinal Mushrooms over the Last Five Years
Nutrients · 30.05.2025 · 17 (11) · 1887
DOI: 10.3390/nu17111887 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 30.05.2025. Verfasst von Sandra Górska-Jakubowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland. Hauptthemen laut MEDLINE: Agaricales, Antineoplastic Agents, Neoplasms, Biological Products. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Normal-Hong Kong Baptist University, Guangdong Higher Education Upgrading Plan.
Abstract (Originalsprache)
In recent years, the incidence rate of cancer has been on the rise all over the world, and the age of cancer patients has shown a younger trend, which seriously endangers patients’ health. Edible/medicinal mushrooms have not only become a new source of nutritional supplements but have also emerged as a promising adjunct to conventional medicine, either by directly or indirectly killing tumor cells and enhancing immunity, or through their use in conjunction with modern cancer therapies to enhance their efficacy or reduce their side-effects, improving patients’ quality of life. Although the anti-cancer potential of edible and medicinal mushrooms has been widely studied in the past, this review focuses on the most recent literature from the last five years, providing an up-to-date and comprehensive summary of the current findings. In this review, we aim to analyze the anti-cancer effects of edible/medicinal mushrooms, including Schizophyllum commune, Trametes versicolor, Grifola frondosa, Ganoderma lucidum, Lentinula edodes, Laetiporus sulphureus, Boletus edulis, and Phellinus igniarius, as well as their potential anti-cancer mechanisms, providing strong theoretical support for the further development of edible/medicinal mushroom anti-cancer products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland.
- Food Science and Technology Program, Department of Life Sciences, Beijing Normal-Hong Kong Baptist University, Zhuhai 519087, China.
- School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
ORCID-Profile: Sandra Górska-Jakubowska, Yingzi Wu, Jadwiga Turło, Baojun Xu
Förderung
- Beijing Normal-Hong Kong Baptist University
- Guangdong Higher Education Upgrading Plan
Zitieren
APA
Górska-Jakubowska, S., Wu, Y., Turło, J., & Xu, B. (2025). Critical Review on the Anti-Tumor Activity of Bioactive Compounds from Edible and Medicinal Mushrooms over the Last Five Years. Nutrients, 17(11), 1887. https://doi.org/10.3390/nu17111887
Vancouver
Górska-Jakubowska S, Wu Y, Turło J, Xu B. Critical Review on the Anti-Tumor Activity of Bioactive Compounds from Edible and Medicinal Mushrooms over the Last Five Years. Nutrients. 2025;17(11):1887. doi:10.3390/nu17111887
BibTeX
@article{GrskaJakubowska2025,
author = {Górska-Jakubowska, Sandra and Wu, Yingzi and Turło, Jadwiga and Xu, Baojun},
title = {Critical Review on the Anti-Tumor Activity of Bioactive Compounds from Edible and Medicinal Mushrooms over the Last Five Years},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {11},
pages = {1887},
doi = {10.3390/nu17111887}
}
EUVIMED